No Blood Needed Thanks to Innovative Medical Technology
2008年9月27日 - 3:41AM
PRニュース・ワイアー (英語)
SYDNEY, Australia, Sept. 26 /PRNewswire/ -- A non-invasive blood
monitoring device that removes the need to draw blood to monitor
patients has won the 2008 Kerrin Rennie Award for Excellence in
Medical Technology. The award was presented to Masimo Corporation
on 24 September at the Medical Technology Association of Australia
(MTAA) dinner in Sydney. The Radical-7 Pulse CO-Oximeter from
Masimo Corporation continuously and non-invasively measures blood
constituents in patients without having to draw blood. The device
uses multiple wavelengths of light in a single, simple to apply
sensor. It can be used reliably in different care settings, for
example at the patient's bedside or during transport. In addition
to its unique use of algorithms to ensure accurate patient
monitoring, the Radical-7 includes a unique technology platform
that allows for additional features to be added as simple software
upgrades. In congratulating the winner, Anne Trimmer, MTAA CEO,
said: "Masimo's Oximeter is an excellent example of innovation in
the medical technology sector. It benefits the patient, the
clinician and the health system." The Kerrin Rennie Award for
Excellence in Medical Technology -- Improving Quality of Life
recognises the innovative and extraordinary contribution of medical
technology in improving health outcomes of Australian patients. The
award dinner was held as part of a two-day conference on medical
technology from Wednesday 24 - Thursday 25 September at Star City
in Sydney. Companies could enter products launched in Australia
between 1 January 2007 and 1 August 2008 used in the diagnosis,
prevention, treatment or management of disease and disability.
Entries were judged by an independent panel. The other finalists
are: Ex-Press Shunt -- Device Technologies The Ex-Press miniature
glaucoma shunt is an implant used to drain off excess fluid in the
eye and to reduce intraocular pressure. The device creates a
permanent pathway for excess fluid to drain from the eye and
maintains a more normal pressure in the eye. The Ex-Press Shunt is
an improved technology that causes less post operative trauma and
fewer adverse events. HCO 1100 Protein Permeable Membrane -- Gambro
The HCO 1100 Protein-Permeable Membrane is designed to improve the
treatment of multiple myeloma patients with acute renal failure by
removing larger molecules from blood particularly serum Free Light
Chains (FLC), the protein present at abnormally high concentrations
in this patient group. High levels of FLCs in the blood circulating
through the kidney present a major cause of renal impairment. This
new membrane technology in combination with chemotherapy can
prevent the patient from developing end stage renal disease and
having to rely on dialysis for survival. The Medical Technology
Association of Australia (MTAA) is the national peak industry body
representing companies in the medical technology industry. MTAA
aims to ensure the benefits of modern, innovative and reliable
medical technologyare delivered to the community for a healthier
Australia. http://www.mtaa.org.au/ Media contact: Marion Demann
MTAA 0416 625 678 DATASOURCE: The Medical Technology Association of
Australia CONTACT: Marion Demann of The Medical Technology
Association of Australia, 0416 625 678 Web site:
http://www.mtaa.org.au/
Copyright